MedPath

A clinical study to compare the effect of extract and crude form of Unani drug in the treatment of Gouty Arthritis.

Phase 2
Completed
Conditions
Health Condition 1: M109- Gout, unspecified
Registration Number
CTRI/2020/10/028663
Lead Sponsor
Ayurvedic and Unani Tibbia College Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

Patient with clinical features of gouty arthritis, Serum uric acid more than 7 mg/dL, Patient willing to discontinue the drugs taking for the treatment of gouty arthritis, Patient willing to participate in the study and sign the informed consent form

Exclusion Criteria

Patient having Gouty arthritis with its complications such as Tophi and renal stones etc, Pregnant and lactating women, Patient receiving Uric acid elevating drugs eg, Pyrazinamide, Thiazide group of diuretics / Aspirin / NSAIDs and Anti-gouty drugs, Renal insufficiency, Hepatic insufficiency, Cardiovascular disorders, Haemopoietic disorders, Patient suffering from malignancy, taking chemo and radiotherapy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath